STAMLER JONATHAN S has a total of 24 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are EPSHTEJN OLEG ILICH, LOW PHILIP S and CYTOSCAN SCIENCES LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 19 | |
#2 | WIPO (World Intellectual Property Organization) | 5 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Machines | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Stamler Jonathan S | 24 |
#2 | Toone Eric J | 4 |
#3 | Went Gregory T | 3 |
#4 | Liu Limin | 3 |
#5 | Nudelman Raphael | 2 |
#6 | Hausladen Alfred | 2 |
#7 | Zenn Michael R | 2 |
#8 | Mcmahon Timothy J | 2 |
#9 | Singel David J | 2 |
#10 | Gow Andrew J | 1 |
Publication | Filing date | Title |
---|---|---|
US2012121720A1 | Modulation of beta 2 adrenergic receptors by inhibitors of EGLN3 or pVHL | |
US2007123585A1 | Nitroglycerin therapy for those unable to metabolize nitroglycerin | |
WO2005034860A2 | Thiol reactive agents as a therapeutic modality | |
US2006094648A1 | Methods for treating or preventing ischemic injury |